The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE launches annual award to honour changemakers
Sharjah Police recovers AED 500,000 in stolen goods in under 3 hours
UAE welcomes Gaza agreement for Hamas disarmament
Sheikh Abdullah meets UK Foreign Secretary in London
H.H. Sheikh Hamdan attends GCC joint military drill in Bahrain
UAE President discusses regional developments with Syrian counterpart
UAE strongly condemns renewed Iranian hostile attack on Kuwait
UAE condemns Damietta Port incident, Egypt investigation continues
UAE fuel prices to go up in August
H.H. Sheikh Mohamed announces scholarships for Serbian students at UAE universities
Abu Dhabi sets January deadline to remove junk food at supermarket checkouts
Sheikh Abdullah expresses UAE's solidarity during call with Jordanian, Egyptian FMs
Dubai population crosses 4.5 million by end of 2025
UAE President discusses bilateral cooperation with Slovak Prime Minister
UAE's Abdulla Al Hamed discusses digital safety with TikTok
Emirati mountaineer becomes youngest Arab to climb over 7,000 metres
UAE stands in solidarity with Japan after deadly earthquake
UAE Floating Hospital fits 51 prosthetic limbs for Palestinian amputees
UAE discusses digital governance, content safety with Meta
UAE President and Greek Prime Minister discuss boosting trade ties
